These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32125773)

  • 41. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.
    Ferraiuolo L; Meyer K; Sherwood TW; Vick J; Likhite S; Frakes A; Miranda CJ; Braun L; Heath PR; Pineda R; Beattie CE; Shaw PJ; Askwith CC; McTigue D; Kaspar BK
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6496-E6505. PubMed ID: 27688759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS.
    Coyne AN; Lorenzini I; Chou CC; Torvund M; Rogers RS; Starr A; Zaepfel BL; Levy J; Johannesmeyer J; Schwartz JC; Nishimune H; Zinsmaier K; Rossoll W; Sattler R; Zarnescu DC
    Cell Rep; 2017 Oct; 21(1):110-125. PubMed ID: 28978466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
    Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
    Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
    Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
    Ichiyanagi N; Fujimori K; Yano M; Ishihara-Fujisaki C; Sone T; Akiyama T; Okada Y; Akamatsu W; Matsumoto T; Ishikawa M; Nishimoto Y; Ishihara Y; Sakuma T; Yamamoto T; Tsuiji H; Suzuki N; Warita H; Aoki M; Okano H
    Stem Cell Reports; 2016 Apr; 6(4):496-510. PubMed ID: 26997647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions.
    Codron P; Cassereau J; Vourc'h P; Veyrat-Durebex C; Blasco H; Kane S; Procaccio V; Letournel F; Verny C; Lenears G; Reynier P; Chevrollier A
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):446-456. PubMed ID: 29382228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
    Chen Y; Yi Y; Xu J; Chan WK; Loh YH
    FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges.
    Zhao A; Pan Y; Cai S
    Stem Cell Rev Rep; 2020 Jun; 16(3):482-502. PubMed ID: 31916190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes.
    Wong CO; Venkatachalam K
    Hum Mol Genet; 2019 Aug; 28(16):2799-2810. PubMed ID: 31107959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers.
    DeJesus-Hernandez M; Finch NA; Wang X; Gendron TF; Bieniek KF; Heckman MG; Vasilevich A; Murray ME; Rousseau L; Weesner R; Lucido A; Parsons M; Chew J; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; de Boer J; Asmann YW; Petrucelli L; Boylan KB; Dickson DW; van Blitterswijk M; Rademakers R
    Acta Neuropathol; 2017 Aug; 134(2):255-269. PubMed ID: 28508101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients.
    Prudencio M; Gonzales PK; Cook CN; Gendron TF; Daughrity LM; Song Y; Ebbert MTW; van Blitterswijk M; Zhang YJ; Jansen-West K; Baker MC; DeTure M; Rademakers R; Boylan KB; Dickson DW; Petrucelli L; Link CD
    Hum Mol Genet; 2017 Sep; 26(17):3421-3431. PubMed ID: 28637276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.
    Ray A; Joshi JM; Sundaravadivelu PK; Raina K; Lenka N; Kaveeshwar V; Thummer RP
    Stem Cell Rev Rep; 2021 Dec; 17(6):1954-1974. PubMed ID: 34100193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Familial Amyotrophic Lateral Sclerosis].
    Suzuki N; Nishiyama A; Kato M; Warita H; Aoki M
    Brain Nerve; 2019 Nov; 71(11):1169-1181. PubMed ID: 31722303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bromodomain inhibitors regulate the C9ORF72 locus in ALS.
    Zeier Z; Esanov R; Belle KC; Volmar CH; Johnstone AL; Halley P; DeRosa BA; Khoury N; van Blitterswijk M; Rademakers R; Albert J; Brothers SP; Wuu J; Dykxhoorn DM; Benatar M; Wahlestedt C
    Exp Neurol; 2015 Sep; 271():241-50. PubMed ID: 26099177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells.
    Kim YM; Kang YG; Park SH; Han MK; Kim JH; Shin JW; Shin JW
    Stem Cell Res Ther; 2017 Jun; 8(1):139. PubMed ID: 28595633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.